Skip to content
PubMed This is a summary of 73 peer-reviewed journal articles Updated
Endocrinology · Immunotherapy-Induced Hypophysitis

Immunotherapy-Induced Hypophysitis: A Patient Guide

At a Glance

Immunotherapy-induced hypophysitis can reduce pituitary signals that control cortisol and other hormones. Daily replacement, a personalized sick-day plan, emergency preparation, and endocrinology follow-up can help prevent adrenal crisis while cancer treatment is coordinated safely.

Immunotherapy-induced hypophysitis (IIH) occurs when your body’s immune system, activated by cancer-fighting drugs, mistakenly attacks your pituitary gland. This tiny organ at the base of your brain acts as a command center, sending out signals that tell your other glands how to regulate vital functions like metabolism, blood pressure, and your response to stress. When the immune system causes inflammation in this gland, those signals can be disrupted or stopped entirely, leading to a drop in essential hormones [1][2].

The most critical consequence of this condition is the loss of cortisol, often called the “stress hormone.” Without enough cortisol, your body cannot maintain its blood pressure or energy balance during illness or injury, which can lead to a life-threatening emergency known as an adrenal crisis. Because of this risk, managing IIH requires you to be vigilant about symptoms like extreme fatigue, nausea, or dizziness. Protecting yourself involves more than just daily hormone replacement; it requires a specialized safety plan known as “sick day rules,” where you temporarily increase your medication during times of physical stress to mimic the body’s natural response [3][4].

While a diagnosis of hypophysitis represents a new health challenge, it is one that can be managed successfully. For most patients, the damage to the cells that signal cortisol production is long-term, meaning you will likely need to take daily hormone replacement medication for the foreseeable future. Other hormone systems, like the thyroid or gonadal axes, may eventually recover, but you will need regular monitoring by an endocrinologist to know for sure. Importantly, this diagnosis does not usually mean you have to permanently stop your cancer treatment. Many people are able to stabilize their hormone levels and safely continue the immunotherapy that is working against their cancer, provided they have a strong partnership with their medical team [5][6].

Living with IIH is about finding a new rhythm and being prepared. By wearing a medical alert bracelet, carrying an emergency injection kit, and strictly following your personalized sick-day plan, you can significantly reduce the risks associated with the condition. This guide is designed to help you move from the initial shock of diagnosis toward a place of confidence, where you have the tools and knowledge to manage your hormone health while staying focused on your primary goal of fighting cancer [7][8].

Common questions in this guide

What is immunotherapy-induced hypophysitis?
Immunotherapy-induced hypophysitis is inflammation of the pituitary gland caused by the immune response to cancer immunotherapy. It can interrupt hormone signals, especially those needed to produce cortisol, which helps the body respond safely to illness or injury.
Why is low cortisol dangerous with hypophysitis?
Cortisol helps maintain blood pressure and energy during physical stress. Too little cortisol can lead to an adrenal crisis, a life-threatening emergency, so follow your personalized emergency plan for severe fatigue, nausea, dizziness, or other concerning symptoms.
What are sick-day rules for immunotherapy-induced hypophysitis?
Sick-day rules are a personalized plan for temporarily increasing hormone replacement when illness, injury, or another physical stress increases the body’s need for cortisol. Ask your medical team exactly when to adjust your medication and when to seek emergency care.
Will I need hormone replacement permanently?
The pituitary damage affecting cortisol signals is often long-lasting, so many people need daily hormone replacement for the foreseeable future. Other hormone systems, including thyroid or gonadal hormones, may recover, and regular endocrinology monitoring can track changes.
Can I continue cancer immunotherapy after developing hypophysitis?
A diagnosis of hypophysitis does not usually require permanently stopping cancer immunotherapy. Once hormone levels are stabilized, many patients can continue treatment safely with close coordination between their oncology and endocrinology teams.
How can I prepare for an adrenal crisis?
Wear a medical alert bracelet, keep an emergency injection kit available, and make sure the people around you understand your sick-day and emergency plan. A pill organizer or phone alarm can also help prevent missed daily hormone doses.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How will we coordinate care between my oncology team and an endocrinologist?
  2. 2.Who should I call first if I feel a sudden 'crash' in my energy or start feeling nauseated?
  3. 3.What is the best way to explain this condition to my family so they know how to help me in an emergency?
  4. 4.Does my current hormone replacement plan adequately cover me for the next round of immunotherapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Diagnosis and Management.

    SirDeshpande P, Hegde SBS, Akhtar H

    Cureus 2025; (17(12)):e98717 doi:10.7759/cureus.98717.

    PMID: 41510421
  2. 2

    Immune Checkpoint Inhibitors and Associated Pituitary Dysfunctions: A Mini-Review.

    Fukuda I

    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2023; (90(2)):149-156 doi:10.1272/jnms.JNMS.2023_90-215.

    PMID: 36823122
  3. 3

    Diagnosis and Management of Adrenal Insufficiency and Adrenal Crisis in the Emergency Department.

    Lentz S, Collier KC, Willis G, Long B

    The Journal of emergency medicine 2022; (63(2)):212-220 doi:10.1016/j.jemermed.2022.06.005.

    PMID: 36038436
  4. 4

    Adrenal insufficiency.

    Husebye ES, Pearce SH, Krone NP, Kämpe O

    Lancet (London, England) 2021; (397(10274)):613-629 doi:10.1016/S0140-6736(21)00136-7.

    PMID: 33484633
  5. 5

    Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management.

    Kotwal A

    Current opinion in endocrinology, diabetes, and obesity 2021; (28(4)):427-434 doi:10.1097/MED.0000000000000652.

    PMID: 34183541
  6. 6

    The side effects of immune checkpoint inhibitor therapy on the endocrine system.

    Goyal I, Pandey MR, Sharma R, et al.

    The Indian journal of medical research 2021; (154(4)):559-570 doi:10.4103/ijmr.IJMR_313_19.

    PMID: 35435341
  7. 7

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

    Bornstein SR, Allolio B, Arlt W, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.

    PMID: 26760044
  8. 8

    Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.

    Nguyen H, Shah K, Waguespack SG, et al.

    Endocrine-related cancer 2021; (28(7)):419-431.

    PMID: 33890870

This guide explains immunotherapy-induced hypophysitis and hormone-safety planning for informational purposes only and does not replace medical advice. Follow the sick-day and emergency plan made with your oncology and endocrinology teams.

Get notified when new evidence is published on Immunotherapy induced hypophysitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.